Mitochondrial SIRT3 Deficiency Mediates Age-Related Decline in B Cell Somatic Hypermutation via Impaired Oxidative Phosphorylation and DNA Repair

Kevin Wolf (MD/PhD)· Mar 25, 2026

Mechanism: Age-related mtDNA damage reduces SIRT3 activity, leading to hyperacetylation of metabolic and DNA repair enzymes, which impairs OxPhos and somatic hypermutation (SHM) in B cells. Readout: Readout: NAD+ supplementation or SIRT3 activation rescues OxPhos, increases SHM frequency by up to 35%, and restores high antibody affinity.

Hypothesis

Age‑accumulated mitochondrial DNA (mtDNA) mutations reduce the expression or activity of the mitochondrially‑encoded SIRT3 deacetylase, leading to hyperacetylation of metabolic enzymes and DNA‑repair factors in germinal center B cells. This metabolic‑epigenetic block forces B cells to rely on glycolysis, stalls the oxidative‑phosphorylation (OxPhos) transition required for affinity maturation, and diminishes the efficiency of activation‑induced cytidine deaminase (AID)‑mediated somatic hypermutation (SHM). Consequently, the antibody repertoire contracts and affinity maturation fails, reproducing the aged humoral phenotype.

Mechanistic Rationale

mtDNA‑SIRT3 link – The SIRT3 gene is nuclear‑encoded but its activity depends on NAD+ generated by OxPhos; mtDNA damage lowers NAD+ levels, decreasing SIRT3 deacetylase activity {1}.
Acetyl‑mediated metabolic shift – Hypoactive SIRT3 hyperacetylates pyruvate dehydrogenase complex and succinate dehydrogenase, suppressing TCA flux and forcing a glycolytic phenotype, which is incompatible with the quiescent OxPhos state of mature germinal centers {2}.
DNA‑repair consequence – SIRT3 also deacetylates Ku70 and RAD51; loss of SIRT3 activity impairs non‑homologous end joining and homologous recombination, increasing the mutagenic load of AID‑induced DNA lesions and reducing successful SHM {3}.
Clonal outcome – B cells with defective SIRT3 show reduced BCL6 upregulation, impaired class‑switch recombination, and accumulation of stress‑response markers, mirroring Tfam‑knockout phenotypes {4}.

Testable Predictions

Prediction 1: In aged mice, germinal center B cells will exhibit lower mtDNA‑encoded SIRT3 protein activity and higher acetylation of metabolic enzymes compared with young mice. Restoring NAD+ (e.g., with NR supplementation) or overexpressing mitochondrially‑targeted SIRT3 will rescue OxPhos levels and increase SHM frequency.
Prediction 2: Introducing a catalytically dead SIRT3 mutant into young B cells will phenocopy the aged GC defect: decreased Bcl6, reduced OxPhos, and impaired affinity maturation despite intact mtDNA copy number.
Prediction 3: Single‑cell multi‑omics of human peripheral B cells from young vs. elderly donors will reveal a negative correlation between mtDNA mutation load (especially in MT‑ND5, MT‑CO1) and SIRT3 activity signatures, predicting reduced clonal diversity and lower somatic hypermutation rates.

Falsifiability

If aged B cells show normal SIRT3 activity and acetylation status despite high mtDNA mutation burden, or if SIRT3 restoration fails to improve OxPhos, SHM, or antibody affinity, the hypothesis would be refuted. Conversely, demonstrating that SIRT3 manipulation alone—without altering mtDNA copy number—can rescue or impair GC B cell function would support the causal role of mitochondrial signaling in immune aging.

References

[1] https://pmc.ncbi.nlm.nih.gov/articles/PMC10960012/ [2] https://pmc.ncbi.nlm.nih.gov/articles/PMC11262065/ [3] https://frontlinegenomics.com/b-cell-responses-belittled-in-mitochondrial-disorders/ [4] https://doi.org/10.1111/acel.12199

Hypothesis

Mechanistic Rationale

mtDNA‑SIRT3 link – The SIRT3 gene is nuclear‑encoded but its activity depends on NAD+ generated by OxPhos; mtDNA damage lowers NAD+ levels, decreasing SIRT3 deacetylase activity {1}.

Acetyl‑mediated metabolic shift – Hypoactive SIRT3 hyperacetylates pyruvate dehydrogenase complex and succinate dehydrogenase, suppressing TCA flux and forcing a glycolytic phenotype, which is incompatible with the quiescent OxPhos state of mature germinal centers {2}.

DNA‑repair consequence – SIRT3 also deacetylates Ku70 and RAD51; loss of SIRT3 activity impairs non‑homologous end joining and homologous recombination, increasing the mutagenic load of AID‑induced DNA lesions and reducing successful SHM {3}.

Clonal outcome – B cells with defective SIRT3 show reduced BCL6 upregulation, impaired class‑switch recombination, and accumulation of stress‑response markers, mirroring Tfam‑knockout phenotypes {4}.

Testable Predictions

Prediction 1: In aged mice, germinal center B cells will exhibit lower mtDNA‑encoded SIRT3 protein activity and higher acetylation of metabolic enzymes compared with young mice. Restoring NAD+ (e.g., with NR supplementation) or overexpressing mitochondrially‑targeted SIRT3 will rescue OxPhos levels and increase SHM frequency.

Prediction 2: Introducing a catalytically dead SIRT3 mutant into young B cells will phenocopy the aged GC defect: decreased Bcl6, reduced OxPhos, and impaired affinity maturation despite intact mtDNA copy number.

Prediction 3: Single‑cell multi‑omics of human peripheral B cells from young vs. elderly donors will reveal a negative correlation between mtDNA mutation load (especially in MT‑ND5, MT‑CO1) and SIRT3 activity signatures, predicting reduced clonal diversity and lower somatic hypermutation rates.

Falsifiability